Investigators from Cedars-Sinai Cancer have identified an investigational therapeutic approach that could be effective against treatment-resistant prostate cancer. Results of their Phase II clinical trial, published in Molecular ...
Nov 2, 2022
0
73
A multi-institution study led by Rohan Dharmakumar, Ph.D., of Indiana University School of Medicine, has identified that iron drives the formation of fatty tissue in the heart and leads to chronic heart failure in about 50% ...
Nov 1, 2022
0
1286
A new breast cancer test could detect women who are less likely to respond to a standard breast cancer treatment—and could help improve treatment for these women by giving them other treatment options earlier.
Nov 1, 2022
0
42
RNA, the molecule that gave rise to life, has been shown to be essential for repairing human genetic material and preventing mutations that might lead to developing cancer. Recent advances in research, such as those published ...
Oct 28, 2022
0
77
A fault in cells that form a key part of the immune system can be repaired with a pioneering gene editing technique, finds new research demonstrated in human cells and mice, led by UCL scientists.
Oct 26, 2022
0
67
A new approach to cancer immunotherapy that uses one type of immune cell to kill another—rather than directly attacking the cancer—provokes a robust anti-tumor immune response that shrinks ovarian, lung, and pancreatic ...
Oct 25, 2022
0
89
Researchers have developed a system which uses light stimulation to modulate brain waves. This opens up new avenues to explore for possible treatment of conditions such as epilepsy, Parkinson's and migraine.
Oct 21, 2022
0
102
Researchers from the Georg-Speyer-Haus in Frankfurt am Main, Germany, were able to identify a new approach for the therapy of colorectal cancer (CRC) as part of an interdisciplinary project of the LOEWE Center Frankfurt Cancer ...
Oct 20, 2022
0
158
Stopping prostate cancer cells from morphing into other cell types can overcome the resistance they develop to widely prescribed therapies, a study led by UT Southwestern scientists suggests. The findings, published in Nature ...
Oct 18, 2022
0
37
About one-fourth of recurrent estrogen receptor-positive (ER+) breast cancers lose ER expression, which renders them resistant to endocrine therapy and able to grow uncontrolled. A team of researchers at Baylor College of ...
Oct 17, 2022
0
51
